Novartis, Pfizer, GSK, Abbot Drugs Go On Sale As NHI Price Listings
This article was originally published in PharmAsia News
Executive Summary
Seebri, a new COPD drug from Novartis and three other new drugs launched on the same day that Japan’s National Health Insurance prices for 22 items from 15 new ingredients were listed.